Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies.
Deng S, Derebail S, Weiler VJ, Fong Ng J, Maroto-Martin E, Chatterjee M, Giorgetti G, Chakraborty C, Kalhotra P, Du T, Yao Y, Prabhala R, Shammas M, Gulla A, Aktas Samur A, Samur MK, Qiu L, Anderson KC, Fulciniti M, Munshi NC.
Deng S, et al. Among authors: chatterjee m.
Blood Adv. 2024 Aug 13;8(15):4025-4034. doi: 10.1182/bloodadvances.2023012298.
Blood Adv. 2024.
PMID: 38861273
Free PMC article.